Literature DB >> 29605725

Utility of Viscoelastic Assays Beyond Coagulation: Can Preoperative Thrombelastography Indices Predict Tumor Histology, Nodal Disease, and Resectability in Patients Undergoing Pancreatectomy?

Hunter B Moore1, Alessandro Paniccia2, Peter J Lawson2, Robert J Torphy2, Trevor L Nydam2, Ernest E Moore2, Martin D McCarter2, Richard D Schulick2, Barish H Edil2.   

Abstract

BACKGROUND: Hypercoagulability and malignancy have been linked since the 1860s. However, the impact of different neoplasms on multiple components of the coagulation system remains poorly understood. Thrombelastography (TEG) enables measurement of coagulation incorporating clotting through fibrinolysis. We hypothesize that specific TEG indices that are associated with hypercoagulability can be appreciated in patients with adenocarcinoma undergoing pancreatic resection. STUDY
DESIGN: Blood samples were obtained from patients undergoing pancreatic resection before surgical incision and assayed with TEG. The 4 indices of coagulation measured by TEG included in the analysis were R time, angle, maximum amplitude, and lysis at 30 minutes. Patient tumor type, nodal disease, and mass resectability were contrasted with TEG indices.
RESULTS: One hundred patients were enrolled over 18 months. The majority (63%) of patients had adenocarcinoma. Patients with adenocarcinoma had increased angle compared with other lesions (49 degrees [interquartile range {IQR} 37 to 59 degrees] vs 43 degrees [IQR 32 to 49 degrees]; p = 0.011). When excluding patients that underwent neoadjuvant therapy, patients with adenocarcinoma had shorter R times (13 minutes [IQR 9 to 16 minutes] vs 14 minutes [IQR 12 to 18 minutes]; p = 0.051), steeper angles (49 degrees [IQR 40 to 59 degrees] vs 43 degrees [IQR 32 to 49 degrees]; p = 0.010), and higher maximum amplitude (67 mm [IQR 61 to 69 mm] vs 62 mm [IQR 57 to 67 mm]; p = 0.017). Nodal disease was associated with a significantly increased angle (49 degrees [IQR 42 to 59 degrees] vs 40 degrees [IQR 32 to 50 degrees]; p = 0.002) and maximum amplitude (64 mm [IQR 61 to 69 mm] vs 62 mm [IQR 56 to 67 mm]; p = 0.017). Patients who underwent successful mass resection had longer R times (14 minutes [IQR 11 to 17 minutes] vs 10 minutes [IQR 9 to 15]; p = 0.033) and shorter angles (44 degrees [IQR 35 to 55 degrees] vs 58 degrees [IQR 45 to 66 degrees]; p = 0.025).
CONCLUSIONS: Patients with adenocarcinoma undergoing pancreatic resection have multiple TEG abnormalities consistent with hypercoagulability. These TEG outputs are associated with tumor type, nodal disease, and probability of a successful resection. The use of preoperative TEG has the potential to aid surgeon and patient discussions on anticipated disease burden and prognosis before resection.
Copyright © 2018 American College of Surgeons. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2018        PMID: 29605725      PMCID: PMC6251405          DOI: 10.1016/j.jamcollsurg.2018.03.031

Source DB:  PubMed          Journal:  J Am Coll Surg        ISSN: 1072-7515            Impact factor:   6.113


  37 in total

Review 1.  Hypercoagulability and Platelet Abnormalities in Inflammatory Bowel Disease.

Authors:  Elena Senchenkova; Hilary Seifert; D Neil Granger
Journal:  Semin Thromb Hemost       Date:  2015-08-13       Impact factor: 4.180

Review 2.  The role of hyperglycaemia and the hypercoagulable state in the pathogenesis of cardiovascular events in diabetes mellitus: implications for hypertension management.

Authors:  Hoong Sern Lim; Robert J MacFadyen; George Bakris; Gregory Y H Lip
Journal:  Curr Pharm Des       Date:  2006       Impact factor: 3.116

3.  Durability of portal venous reconstruction following resection during pancreaticoduodenectomy.

Authors:  Rory L Smoot; John D Christein; Michael B Farnell
Journal:  J Gastrointest Surg       Date:  2006-12       Impact factor: 3.452

4.  Thromboelastographic changes in liver and pancreatic cancer surgery: hypercoagulability, hypocoagulability or normocoagulability?

Authors:  Lesley De Pietri; Roberto Montalti; Bruno Begliomini; Giulia Scaglioni; Giorgia Marconi; Alexia Reggiani; Fabrizio Di Benedetto; Stefano Aiello; Alberto Pasetto; Gianluca Rompianesi; Giorgio E Gerunda
Journal:  Eur J Anaesthesiol       Date:  2010-07       Impact factor: 4.330

5.  Carcinoma mucins trigger reciprocal activation of platelets and neutrophils in a murine model of Trousseau syndrome.

Authors:  Bojing Shao; Mark G Wahrenbrock; Longbiao Yao; Tovo David; Shaun R Coughlin; Lijun Xia; Ajit Varki; Rodger P McEver
Journal:  Blood       Date:  2011-08-22       Impact factor: 22.113

6.  Thromboelastographic profiles as a tool for thrombotic risk in digestive tract cancer.

Authors:  M L Papa; F Capasso; L Pudore; S Torre; S Mango; V Russo; P Delrio; R Palaia; F Ruffolo; M D d'Eufemia; D De Lucia; M Napolitano; P Di Micco; V Parisi
Journal:  Exp Oncol       Date:  2007-06

7.  Intravascular mucinosis with mucin emboli and thrombosis accompanying adenocarcinomas.

Authors:  H R Pratt-Thomas; R M Smith; K R McMaster; G R Earlywine
Journal:  Pathol Res Pract       Date:  1980-12       Impact factor: 3.250

Review 8.  The role of thrombomodulin lectin-like domain in inflammation.

Authors:  Yi-Heng Li; Cheng-Hsiang Kuo; Guey-Yueh Shi; Hua-Lin Wu
Journal:  J Biomed Sci       Date:  2012-03-27       Impact factor: 8.410

Review 9.  Potential prognostic biomarkers in pancreatic juice of resectable pancreatic ductal adenocarcinoma.

Authors:  Shefali Agrawal
Journal:  World J Clin Oncol       Date:  2017-06-10

10.  Evaluation of serum D-dimer, fibrinogen, and CA19-9 for postoperative monitoring and survival prediction in resectable pancreatic carcinoma.

Authors:  Junli Cao; Zhanzhao Fu; Liming Gao; Xin Wang; Shaohui Cheng; Xiuchao Wang; He Ren
Journal:  World J Surg Oncol       Date:  2017-02-20       Impact factor: 2.754

View more
  4 in total

Review 1.  Pancreatic cancer treatment: better, but a long way to go.

Authors:  Robert J Torphy; Yuki Fujiwara; Richard D Schulick
Journal:  Surg Today       Date:  2020-05-30       Impact factor: 2.549

2.  Net platelet clot strength of thromboelastography platelet mapping assay for the identification of high on-treatment platelet reactivity in post-PCI patients.

Authors:  Daye Cheng; Shuo Zhao; Yiwen Hao
Journal:  Biosci Rep       Date:  2020-07-31       Impact factor: 3.840

3.  The Hypercoagulable Profile of Patients with Bone Tumors: A Pilot Observational Study Using Rotational Thromboelastometry.

Authors:  Andreas G Tsantes; Ilectra Loukopoulou; Dimitrios V Papadopoulos; Ioannis G Trikoupis; Anastasios G Roustemis; Stavros Goumenos; Rozeta Sokou; Konstantina A Tsante; Anastasios G Kriebardis; Panagiotis Koulouvaris; Dimitra Houhoula; Daniele Piovani; Panayiotis J Papagelopoulos; Stefanos Bonovas; Argirios E Tsantes
Journal:  Cancers (Basel)       Date:  2022-08-15       Impact factor: 6.575

4.  Application of Thromboelastography to Predict Lung Cancer Stage.

Authors:  Yaning Zhou; Yijun Guo; Qing Cui; Yun Dong; Xiaoyue Cai; Zhouji Zhang; Xiaoting Wu; Kaiyan Yi; Ming Zhang
Journal:  Technol Cancer Res Treat       Date:  2020 Jan-Dec
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.